Pharmacokinetics of meloxicam administered orally to rabbits (Oryctolagus cuniculus) for 29 days
Authors:
- James W. CarpenterJCJames W. Carpenter
- Butch KuKanichBKButch KuKanich
- Jerome C. NietfeldJNJerome C. Nietfeld
- Micah KohlesMKMicah Kohles
- 1 February 2014
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 75 (2) , 195-199
Abstract
Objective—To determine the pharmacokinetics and safety of meloxicam in rabbits when administered orally for 29 days. Animals—6 healthy rabbits. Procedures—Meloxicam (1.0 mg/kg, PO, q 24 h) was administered to rabbits for 29 days. Blood was collected immediately before (time 0) and 2, 4, 6, 8, and 24 hours after drug administration on days 1, 8, 15, 22, and 29 to evaluate the pharmacokinetics of meloxicam. On day 30, an additional sample was collected 36 hours after treatment. Plasma meloxicam concentrations were quantified with liquid chromatography–mass spectrometry, and noncompartmental pharmacokinetic analysis was performed. Weekly plasma biochemical analyses were performed to evaluate any adverse physiologic effects. Rabbits were euthanatized for necropsy on day 31. Results—Mean ± SD peak plasma concentrations of meloxicam after administration of doses 1, 8, 15, 22, and 29 were 0.67 ± 0.19 μg/mL, 0.81 ± 0.21 μg/mL, 1.00 ± 0.31 μg/mL, 1.00 ± 0.29 μg/mL, and 1.07 ± 0.19 μg/mL, respectively; these concentrations did not differ significantly among doses 8 through 29. Results of plasma biochemical analyses were within reference ranges at all time points evaluated. Gross necropsy and histologic examination of tissues revealed no clinically relevant findings. Conclusions and Clinical Relevance—Plasma concentrations of meloxicam for rabbits in the present study were similar to those previously reported in rabbits that received 1. 0 mg of meloxicam/kg, PO every 24 hours, for 5 days. Results suggested that a dosage of 1. 0 mg/kg, PO, every 24 hours for up to 29 days may be safe for use in healthy rabbits.Keywords
This publication has 17 references indexed in Scilit:
- Single and Multiple-Dose Pharmacokinetics of Meloxicam After Oral Administration to the Rabbit (Oryctolagus cuniculus)Journal of Zoo and Wildlife Medicine, 2009
- Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogsAmerican Journal of Veterinary Research, 2007
- Analgesic efficacy of preoperative administration of meloxicam or butorphanol in onychectomized catsJournal of the American Veterinary Medical Association, 2005
- Effects of meloxicam on severity of lameness and other clinical signs of osteoarthritis in dogsJournal of the American Veterinary Medical Association, 2004
- Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritisVeterinary Record, 2003
- In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogsAmerican Journal of Veterinary Research, 2002
- Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine bloodAmerican Journal of Veterinary Research, 2002
- Safety and efficacy of preoperative administration of meloxicam, compared with that of ketoprofen and butorphanol in dogs undergoing abdominal surgeryAmerican Journal of Veterinary Research, 2001
- Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and catsJournal of the American Veterinary Medical Association, 2000
- Clinical Pharmacokinetics of MeloxicamClinical Pharmacokinetics, 1999